Learn more

FEINSTEIN INST MEDICAL RES

Overview
  • Total Patents
    104
  • GoodIP Patent Rank
    19,039
  • Filing trend
    ⇩ 10.0%
About

FEINSTEIN INST MEDICAL RES has a total of 104 patent applications. It decreased the IP activity by 10.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are SHANGHAI 1ST PEOPLES HOSPITAL, KOBENHAVNS UNIV and THE FEINSTEIN INST MEDICAL RES.

Patent filings per year

Chart showing FEINSTEIN INST MEDICAL RESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tracey Kevin J 29
#2 Wang Ping 17
#3 Al-Abed Yousef 16
#4 Wang Haichao 10
#5 Chavan Sangeeta S 8
#6 Diamond Betty A 8
#7 Yang Huan 7
#8 Hand Conor 6
#9 Li Wei 6
#10 Young Derek 6

Latest patents

Publication Filing date Title
EP3639742A1 Systems and methods for measurement of gas concentration difference between inhalation and exhalation
WO2020219072A1 Systems and methods for delivering neuromodulation to reduce cortical spreading depolarization in animals including humans
US2019321623A1 Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
US2019255175A1 Activation of trpa1+ nociceptors in the vagus nerve attenuates systemic inflammation
US2019175239A1 Fastener
US2019111434A1 Smartbox and uses thereof
WO2018223118A1 Use of tetranectin and peptide agonists to treat inflammatory diseases
US2018344808A1 Haptoglobin derivative for treatment of sepsis and acetaminophen-induced liver damage
WO2018209058A1 Intraclonal diversification and evolution in cll
US2018318111A1 Prosthetic limb and prosthetic limb attachment for swimming
WO2019203850A1 Systems and methods for delivering non-invasive neuromodulation to reduce the effects of shock and traumatic brain injury in animals and humans and to prolong life
WO2018089400A1 Iguratimod as an mif inhibitor
WO2018049095A1 Methods of treating hypertension
AU2017305946A1 C1q and HMBG1 fusion proteins and uses thereof
US2017332711A1 Medical gown
US2020289156A1 Introducer and methods of use thereof
AU2017220314A1 Lymphatic system neuromodulation and uses thereof
US2019030124A1 Use of dermcidin in sterile inflammatory conditions
EP3359186A1 Inhibition of autism spectrum disorder using decoy antigens to maternal brain-reactive antibodies
EP3331545A1 Hemichannel extracellular-domain specific agents for treating sepsis